Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VOR - Vor Biopharma: Targeted Therapies For Transplants

VOR - Vor Biopharma: Targeted Therapies For Transplants

Vor Biopharma Inc.
  • Vor has a lead asset entering phase 1 clinical trials for AML that has the potential to become the standard of care for stem cell transplants.
  • The company also has a platform and process to expand the use of their lead asset, VOR33, and design other cell therapies for beyond AML.
  • This has created an investment opportunity in Vor based on the patient need, market size, and upcoming clinical catalysts over the next 6-12 months.

For further details see:

Vor Biopharma: Targeted Therapies For Transplants
Stock Information
Company Name: Vor Biopharma Inc.
Stock Symbol: VOR
Market: NASDAQ
Website: vorbio.com
Menu
VOR VOR Quote VOR Short VOR News VOR Articles VOR Message Board
Get VOR Alerts

News, Short Squeeze, Breakout and More Instantly...